Stock Ratings / Consumer Discretionary / AMN / forecast

ASTH (58) NSP (20) ICFI (71) MAN (41) ⌘ Pro Terminal →

AMN Healthcare Services Inc (AMN) 12-Month Stock Forecast & Price Target Cone

$46.94 +0.47% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $46.89

AMN Healthcare Services Inc (AMN) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $1.82B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $46.89 (-0.11%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 8.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY • 50.6% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE-2.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AMN)Realized 20D OHLCV Swing Band: ±10.3%

Deterministic 5-Pillar Attribution (53/100 Composite)

🔍 WHY AMN SCORES 53/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+14/20 pts (26% of score)

FRED Regime × Technicals: 92% of 52W Range • RSI-14 at 75.9 (OVERBOUGHT (>70))

▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (21% of score)

20D Institutional Volume Accumulation (±10.3% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$36.52+10.9% Next Q

Q2 (-2Q)

Grade D$40.49+18.6% Next Q

Q3 (-1Q)

Grade C-$48.01-2.2% Next Q

Current

Grade D+$46.94-0.9% Hist 90D α

Trajectory: D (45) → D+ (53)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a AMN Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While AMN currently carries a cautious 53/100 (D+) rating due to Insider Conviction & Share Dilution (9/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($37.21) and Max Pain ($49.29) forces dealer call-delta covering toward $54.14.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $AMN• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “AMN Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 53%NO 47%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your AMN Position Size: $10,000

Shares at $46.94: 213.0 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $35.79

$7,625

$-2,375 (-23.8%)

12M Consensus BaseTarget $45.88

$9,774

$-226 (-2.3%)

12M Bull Case BreakoutTarget $54.14

$11,534

+$1,534 (+15.3%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (32 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 6

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$48	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$51	69%	B
JP MorganUS Large-Cap Research	SELL	$41	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AMN)

✓Walkthrough of AMN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

AMN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +129.31%▲ ASCENDING CHANNEL

2026-10-30O $46.94H $47.90L $46.46C $46.94VOL 599.0K

RES: $50.08SUP: $35.89SMA50: $37.21SMA200: $28.46

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AMN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AMN Butterfly Map → + Track AMN →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -8.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AMN today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AMN. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AMN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AMN)

Consumer Discretionary Rank #584 of 1011 ⚔️ ASTH vs AMN Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (AMN vs. ASTH, NSP, ICFI, MAN)

Industry: Professional Services (48 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, AMN Healthcare Services Inc (AMN) ranks #584 by composite RQD confidence (53/100, grade D+) and #425 by equity capitalization ($1.82B). Within this direct 5-issuer industry benchmark cohort, ICFI leads on earnings valuation at 18.7x trailing P/E, while ICFI leads on capital efficiency and profitability with 8.1% ROIC and 37.2% gross margin. ICFI currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with AMN at 53/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
AMN ACTIVE AMN Healthcare Services Inc	D+	53/100	—	28.3%	-7.2%	+0.47%	$1.82B	Benchmark Subject
ASTH Astrana Health Inc.	D+	58/100	75.7x	—	4.6%	-0.14%	$1.82B	/asth-vs-amn →
NSP Insperity Inc.	E	20/100	—	13.2%	-8.9%	-10.38%	$1.77B	/nsp-vs-amn →
ICFI ICF International Inc.	B-	71/100	18.7x	37.2%	8.1%	+1.25%	$1.72B	/icfi-vs-amn →
MAN ManpowerGroup	D-	41/100	—	16.7%	5.3%	-0.57%	$2.12B	/man-vs-amn →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001142750

In its most recent audited fiscal period (FY2025, filed 2025-12-31), AMN Healthcare Services Inc (AMN) reported GAAP revenue of $2.73B (-8.5% vs. FY2024 revenue of $2.98B , and -27.9% cumulative change since FY2023) , GAAP net income of -$95.7M, operating cash flow of $269.5M, and free cash flow of $233.8M (-2.4% YoY). On the balance sheet, AMN closed FY2025 with $2.09B in total assets against $0 in total debt (Altman Z-Score: 2.76, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$2.73B	-$95.7M	$269.5M	$233.8M	$2.09B	—
FY2024 (FY)	2024-12-31	$2.98B	-$147.0M	$320.4M	$239.5M	$2.42B	—
FY2023 (FY)	2023-12-31	$3.79B	$210.7M	$372.2M	$372.2M	—	—

3. AMN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AMN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, AMN Healthcare Services Inc (NYSE: AMN) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $46.94 (+0.47% 1D, market cap $1.82B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 14/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, AMN ranks #584 in composite RQD confidence.

How does AMN compare to ASTH and NSP in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Professional Services), AMN carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of 28.3%, and ROIC of -7.2%. By comparison, ASTH (Astrana Health Inc.) holds a D+ grade (58/100 RQD, P/E 75.7x, ROIC 4.6%, cap $1.82B) and NSP (Insperity Inc.) posts a E grade (20/100 RQD, P/E N/A, ROIC -8.9%, cap $1.77B). Among the 5-stock peer group, ICFI leads on earnings multiple (18.7x) while ICFI leads on capital efficiency (8.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AMN?

Per AMN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001142750), AMN Healthcare Services Inc generated $2.73B in revenue (-8.5% YoY), -$95.7M in net income, and $233.8M in free cash flow against $2.09B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AMN trading relative to its 50-day, 200-day, and 52-week technical levels?

AMN last traded at $46.94 (+0.47% on volume of 498,646 shares), positioning the stock +26.15% above its 50-day simple moving average ($37.21) and +64.93% above its 200-day simple moving average ($28.46). Across its 52-week range of $14.97 to $49.62, AMN sits at the 92.3% percentile with a 14-day RSI of 75.9 (OVERBOUGHT (>70)) and an implied next-earnings move of ±10.3% ($42.11 to $51.77).

AMN Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is AMN's 12-month stock price target?

AMN Healthcare Services Inc (AMN) carries a 12-month consensus base price target of $45.88 (-2.3% from $46.94), with a bull-case target of $54.14 and a bear-case floor of $35.79.

Is AMN stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates AMN D+ (Sell — SELL) with an RQD Confidence score of 53/100.

Direct Sub-Reports: AMN RQD Cockpit AMN 12M Forecast AMN Earnings & Move AMN Dividends & DRIP AMN Insiders & 13F AMN Whale Options AMN Profit Sankey AMN News & Why